A cancer drug that washed out of clinical trials more than 15 years ago may be the key to slowing the progression of Parkinson’s disease, according to a Northwestern Medicine study.
Browsing: Disease Discoveries
Northwestern Medicine scientists have developed a new strategy to treat Parkinson’s disease by mitigating the effects of harmful genetic mutations, according to a recent study.
This article was originally published in the Breakthroughs Newsletter. Find more stories like this, as…
Boosting the activity of newly-created neurons mimicked the effect of antidepressant medication in mouse models, according to a recent study.
Northwestern Medicine scientists have pinpointed the location of dysfunctional brain networks that lead loss of language in primary progressive aphasia, a form of dementia.
Two Northwestern University scientists have received a $3.1 million grant from the National Institute on Aging to collaborate and investigate drug therapies for amyotrophic lateral sclerosis (ALS).
Sesame allergy affects more than 1 million children and adults in the U.S., more than previously known, according to a new Northwestern Medicine study.
Northwestern Medicine scientists have identified a protein that helps reprogram HER2-positive breast cancer cells to survive in the brain, according to a recent study.
Northwestern Medicine scientists have rescued movement in a mouse model of Parkinson’s disease by restoring the intrinsic discharge of nerve cells within the subthalamic nucleus.
A procedure called POEM significantly improved treatment outcomes among patients with achalasia — a rare swallowing disorder — compared with a standard therapy, according to a clinical trial published in JAMA.